Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XARELTO for Embolism venous: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 366 adverse event reports in the FDA FAERS database where XARELTO was used for Embolism venous.

Most Reported Side Effects for XARELTO

Side Effect Reports % Deaths Hosp.
Pulmonary embolism 276 7.9% 27 134
Deep vein thrombosis 234 6.7% 7 98
Drug ineffective 199 5.7% 10 98
Gastrointestinal haemorrhage 198 5.7% 38 148
Cerebrovascular accident 180 5.1% 18 92
Haemoglobin decreased 166 4.7% 21 112
Fall 124 3.5% 39 81
Anaemia 123 3.5% 9 88
Haemorrhage 121 3.5% 28 67
Cerebral haemorrhage 110 3.1% 50 80
Thrombosis 106 3.0% 4 36
Dyspnoea 97 2.8% 11 55
Incorrect dose administered 93 2.7% 8 45
Dizziness 91 2.6% 4 37
Epistaxis 90 2.6% 11 52

Other Indications for XARELTO

Atrial fibrillation (1,492) Cerebrovascular accident prophylaxis (1,433) Product used for unknown indication (683) Deep vein thrombosis (506) Thrombosis prophylaxis (364) Pulmonary embolism (284) Knee arthroplasty (77) Thrombosis (74) Anticoagulant therapy (39) Hip arthroplasty (36)

Other Drugs Used for Embolism venous

RIVAROXABAN (3,125) APIXABAN (2,443) WARFARIN (314) ENOXAPARIN (217) EDOXABAN (115) HEPARIN (89) DABIGATRAN ETEXILATE (60) ASPIRIN (35) FONDAPARINUX (22) DALTEPARIN (21)

Related Pages

XARELTO Full Profile All Embolism venous Drugs XARELTO Demographics XARELTO Timeline